Orthofix appoints Julie Andrews as CFO with inducement stock awards and severance agreement

Orthofix Medical Inc.

Julie Andrews started as CFO on Jan 15, 2024; previously CFO at Smart Wires and SVP Finance at Wright Medical.
Received inducement grants: performance-based RSUs for 65,934 shares (at target), time-based RSUs for 32,967 shares, and options for 76,878 shares.
Severance equal to 1.0x base salary + target bonus (1.5x on change in control) plus COBRA reimbursement for up to 12 months.
Options vest when service conditions met and stock price averages 150% of grant date price over one month.
Interim CFO Geoffrey Gillespie thanked; company expects Andrews to help drive growth and shareholder value.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Julie Andrews

Chief Financial Officer

OFIX · Orthofix Medical Inc.

Effective: 2024-01-15
Filed: January 17, 2024, 6:59 PM ET

On January 15, 2024, Julie Andrews began service as Chief Financial Officer of Orthofix Medical Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Julie Andrews was appointed as Chief Financial Officer at Orthofix Medical Inc..

Action: began service
Role: Chief Financial Officer

Exact text from the filing

On January 15, 2024, Julie Andrews began service as Chief Financial Officer of Orthofix Medical Inc.

View on SEC.gov

Orthofix Medical Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-005068

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.